Yekedüz E - Search Results

1

Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19.

Yekedüz E, Utkan G, Ürün Y. Yekedüz E, et al. Eur J Cancer. 2021 Jul;152:248-249. doi: 10.1016/j.ejca.2021.04.010. Epub 2021 May 17. Eur J Cancer. 2021. PMID: 34016491 Free PMC article. No abstract available.

2

A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma.

Yekedüz E, Arzu Yaşar H, Utkan G, Ürün Y. Yekedüz E, et al. J Oncol Pharm Pract. 2020 Jun;26(4):972-981. doi: 10.1177/1078155220905648. Epub 2020 Feb 25. J Oncol Pharm Pract. 2020. PMID: 32098554

3

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.

Yekedüz E, Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, Utkan G, Ürün Y. Yekedüz E, et al. J Oncol Pharm Pract. 2020 Jul;26(5):1289-1294. doi: 10.1177/1078155220924084. Epub 2020 May 19. J Oncol Pharm Pract. 2020. PMID: 32423324

4

A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer?

Yekedüz E, Karcıoğlu AM, Utkan G, Ürün Y. Yekedüz E, et al. Future Oncol. 2020 Sep;16(25):1879-1881. doi: 10.2217/fon-2020-0501. Epub 2020 Jun 21. Future Oncol. 2020. PMID: 32564611 Free PMC article. No abstract available.

5

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.

Yekedüz E, Utkan G, Ürün Y. Yekedüz E, et al. Eur J Cancer. 2020 Dec;141:92-104. doi: 10.1016/j.ejca.2020.09.028. Epub 2020 Oct 6. Eur J Cancer. 2020. PMID: 33130550 Free PMC article.

6

ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis.

Yekedüz E, Köksoy EB, Akbulut H, Ürün Y, Utkan G. Yekedüz E, et al. Future Oncol. 2021 Jan;17(3):349-357. doi: 10.2217/fon-2020-0671. Epub 2020 Dec 24. Future Oncol. 2021. PMID: 33356539

7

Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?

Yekedüz E, Utkan G, Ürün Y. Yekedüz E, et al. J Oncol Pharm Pract. 2021 Mar;27(2):450-452. doi: 10.1177/1078155220988753. Epub 2021 Jan 20. J Oncol Pharm Pract. 2021. PMID: 33470163

8

In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice?

Yekedüz E, Süer E, Utkan G, Baltacı S, Ürün Y. Yekedüz E, et al. Eur Urol Oncol. 2021 Jun;4(3):515-516. doi: 10.1016/j.euo.2021.02.009. Epub 2021 Mar 10. Eur Urol Oncol. 2021. PMID: 33714722 No abstract available.

9

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?

Yekedüz E, Utkan G, Kanesvaran R, Ürün Y. Yekedüz E, et al. Prostate Int. 2021 Mar;9(1):1-5. doi: 10.1016/j.prnil.2020.03.002. Epub 2020 Mar 31. Prostate Int. 2021. PMID: 33912507 Free PMC article. Review.

10

Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors.

Yekedüz E, Trapani D, Xu W, de Vries EGE, Labaki C, Gyawali B, Gulati S, Nabhan C, Utkan G, Curigliano G, Choueiri TK, Ürün Y. Yekedüz E, et al. Int J Cancer. 2021 Oct 1;149(7):1455-1462. doi: 10.1002/ijc.33708. Epub 2021 Jul 5. Int J Cancer. 2021. PMID: 34124786 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters